Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Advanced Laboratory Medicine, |
RCV000852506 | SCV000995202 | uncertain significance | Atrial fibrillation | 2017-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002332752 | SCV002633388 | uncertain significance | Cardiovascular phenotype | 2020-01-31 | criteria provided, single submitter | clinical testing | The p.R15399Q variant (also known as c.46196G>A), located in coding exon 153 of the TTN gene, results from a G to A substitution at nucleotide position 46196. The arginine at codon 15399 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003489940 | SCV004237075 | uncertain significance | not provided | 2023-02-07 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004559706 | SCV005049310 | uncertain significance | Tibial muscular dystrophy | 2024-03-12 | criteria provided, single submitter | clinical testing |